Montelukast Prescribing at BLACKMORE VALE PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,780
Total Quantity
48.7K
NHS Cost
£2.4K
vs National Avg
+160%
BLACKMORE VALE PARTNERSHIP prescribed 1,780 items of Montelukast over the last 12 months at a cost of £2,445 to the NHS. This is 160% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
153
Jul 2026
132
Jul 2026
147
Jul 2026
134
Jul 2026
139
Jul 2026
141
Jul 2026
147
Jul 2026
151
Jul 2026
167
Jul 2026
141
Jul 2026
164
Jul 2026
164
Prescribing Details
| Total Items | 1,780 |
|---|---|
| Total Quantity | 48,696 |
| Total NHS Cost | £2,445 |
| Presentations | 4 different forms |
| vs National Average | +160% |
Montelukast Prescribing Comparison
| This practice | 1,780 items |
|---|---|
| National average per practice | 685 items |
| Difference | +160% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.